Orthopedic Implant Interlocking Proximal Femoral Pfna Intramedullary Nail

Name: Orthopedic Implant Interlocking Proximal Femoral Pfna Intramedullary Nail
Brand: Xc Technology Co., Ltd.
SKU: 2226132865

Jiangsu, ChinaXc Technology Co., Ltd.

US$70.00

1-4 Pieces

US$68.00

5-19 Pieces

US$65.00

20+ Pieces

Sample price:US$70.00/piece.Request sample

Product profile

Type

None

Syringe

Pfna Intramedullary Nail

Blood Sampling Needle

Pfna Intramedullary Nail

Model NO.

Pfna Intramedullary Nail

Breathing Pattern

Pfna Intramedullary Nail

Animal Anesthesia Machine Control Method

Pfna Intramedullary Nail

Quality Guarantee Period

One Year

Ethylene Oxide Sterilization

Other

Logo Printing

Other

Diameter

9mm/10mm/11mm/12mm/OEM

MOQ

1 PCS

Functional Purpose

Implant Materials & Artificial Organs

Length

180/200/220/240/320/360/380/400

Groups

Trauma Implant

Shipping

DHL/FedEx/UPS/DDP

Warranty

36-Month Warranty

Transport Package

Package

Specification

1pcs

Trademark

XC MEDICO

Origin

China

Company profile

In-stock CapacityFast DeliveryRaw-Materials TraceabilityQuality Assurance

Xc Technology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedCustomization Options: Minor Customization CertifiedExport Year: 6 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤10.31h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXC Medico is identified as a trading company serving the health and medicine sector, with orthopedic instruments as a key product area. The supplier reports 18 years of orthopedic experience, certified production lines and warehouses, raw-material traceability, and 100% finished-product inspection, although inspection is performed by packing staff and only one quality inspector is reported. Service infrastructure is limited: no overseas warehouses, showrooms, agents or branches, and no offline trade-show participation. Formal service procedures, corrective/preventive-action records, and complaint-handling procedures are not provided. Innovation evidence is weak, with no new products in the past year, no ODM, OEM for popular brands, or SDK. Minor customization is available. Certification is mentioned, but specific certificates are not identified. Customer cases are not documented.

After-Sales capabilityThe supplier claims technical support covering preoperative planning, intraoperative assistance, and postoperative traceability and complication management. Against this, it reports no written service procedures or records, no formal corrective/preventive-action mechanism, no documented complaint-handling process, and no overseas warehouses, showrooms, agents or branches; therefore, structured and geographically accessible after-sales capability is not demonstrated.

R&D capabilityThe supplier describes experienced engineers and product development and innovation, but reports no new products during the past year, no ODM service, no OEM for popular brands, and no available SDK. The explicit recent innovation and development offerings therefore indicate a deficiency.

Production capacityThe supplier states that it operates certified production lines and warehouses, has a 668.0 m² manufacturing plant, provides raw-material traceability, and conducts 100% finished-product inspection. However, finished products are checked by packing staff and only one quality inspector is reported; production capability is supported by facility and control claims, but its scale and robustness are only partially evidenced.

Customization capabilityThe supplier explicitly offers minor customization. This confirms some customization capability, but the evidence does not show advanced engineering customization, extensive configuration options, or full OEM/ODM support.